Company Introduction
In 2000, Bloomage Biotech (formerly Bloomage Freda Biopharm Co., Ltd.) took its first steps as a producer of hyaluronic acid using microbial fermentation. After more than 20 years, Bloomage Biotech has emerged as a leading global biotechnology and biomaterial company specializing in hyaluronic acid industrialization. Bloomage Biotech is dedicated to improving people’s quality of life by creating healthier experiences.
Technology
By applying the excellent results of its foundational research, Bloomage Biotech has become a leader in core industry disciplines such as microbial fermentation, enzymatic degradation, and cross-linking. The company has twice revolutionized hyaluronic acid production using microbial fermentation and oligomeric hyaluronic acid production by enzyme digestion.
Products
Bloomage Biotech is on a ceaseless pursuit of "creating technology for a vibrant life." The company primarily focuses on functional sugars, proteins, polypeptides, amino acids, nucleotides, natura active compounds, and other biologically active substances based on hyaluronic acid. Our hyaluronic acid products encompass more than 200 specifications for pharmaceutical, cosmetic, and food-grade applications, which have been widely used in the fields of medicine, medical devices, cosmetics, and nutrition.
Quality
Bloomage Biotech's production of pharmaceutical-grade raw materials complies with the requirements of cGMP in the U.S., GMP in China, and ICHQ7. It has passed on-site audits by the FDA in the U.S., MFDS in Korea, and GMP in China. Bloomage Biotech's food-grade raw material production has been certified under ISO9001 and FSSC22000 food safety systems. Furthermore, the company's cosmetics-grade raw material production has obtained ISO9001 and EFfCI certifications.
Service
Bloomage Biotech is proud to be a trusted strategic partner of world-renowned brands, providing customers with comprehensive products, technical services, and application solutions to meet their unique product needs.
Currently, Bloomage Biotech has earned the trust of over 2,000 renowned global brands in more than 70 countries and regions, fostering close business relationships through delivering exceptional products. Building upon its success, the company has expanded its presence globally, establishing subsidiaries in the U.S., France, Japan, and South Korea. Bloomage Biotech remains committed to innovating and promises to offer even more robust, comprehensive products and solutions to its customers.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Milestone
Name changed to Bloomage Biotechnology Corporation Limited.
Hyafactor™-SG Sclerotium Gum Hydrogel launched.
2019
EFfCI GMP certified.
Feed Additive Production License cotained for feed grade HA.
More DMFs filed at China FDA.
Hymagic™-4D 4D Hyaluronic Acid & microHA™ Super Active Hyaluronic Acid launched.
Biomoist™ Hyaluronic Acid for Oral Care launched.
2018
Environmental Management System and Occupational Health and Safety Management System certified.
HACCP and ISO 22000 certified.
Indian registration for pharmaceutical grade HA obtained.
Hymagic™-AcHA Sodium Acetylated Hyaluronate obtained launched.
2017
Russian registration for pharmaceutical grade HA.
2016
Hyacross™ Hyaluronic Acid Elastomer launched.
Gabarelax™ Gamma Aminobutyric Acid obtained Food Production License and launched.
2015
Fermentation Platform was established.
Japan MF and Canada DMF registration.
Gabacare™ BL98T Aminobutyric Acid was launched.
2014
KDMF registered for pharmaceutical grade HA.
HA Technology Platform established.
2013
Passed US FDA on-site audit.
Subsidiary company established.
2012
China GMP approved.
CEP certifications and US DMFs obtained.
miniHA™ - the world first HA-Oligo by enzymatic degradation successfully launched.
2011
HAPLEX® approved as a New Dietary Ingredient in China.
2008
Pharmaceutical Excipient License obtained.
2004
Bloomage International Investment Group invested in the company.
ISO 9001 certified.
2001